Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | VKTX | KRYS | ||
| Company | Cytokinetics | Viking Thera | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.67 | 53.07 | 184.07 | ||
| High | 49.81 | 53.52 | 191.26 | ||
| Low | 47.41 | 51.95 | 182.02 | ||
| Last | 49.10 | 52.59 | 190.40 | ||
| Change | +1.43 | +0.96 | +8.11 | ||
| % Change | +3.00% | +1.86% | +4.45% | ||
| Volume | 1,640,000 | 2,633,100 | 222,000 | ||
| 20-Day Average Volume | 1,367,540 | 6,187,020 | 276,775 | ||
| Previous Close | 47.67 | 51.63 | 182.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 52.83 | 61.71 | 180.53 | ||
| 20-Day Raw Stochastic | 14.11% | 14.50% | 60.52% | ||
| 20-Day Relative Strength | 41.31% | 40.25% | 56.26% | ||
| Weighted Alpha | -16.08 | +35.28 | +38.35 | ||
| Today's Opinion | 100% Sell | 40% Sell | 56% Buy | ||
| Previous Opinion | 100% Sell | 24% Sell | 32% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.23% since 11/15/24 | +6.07% since 11/15/24 | +11.51% since 11/15/24 | ||
| Low | 47.41 on 11/22/24 | 47.65 on 11/18/24 | 168.88 on 11/18/24 | ||
| High | 52.01 on 11/18/24 | 54.28 on 11/21/24 | 191.26 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -10.63% since 10/22/24 | -15.22% since 10/22/24 | +8.68% since 10/22/24 | ||
| Low | 47.41 on 11/22/24 | 47.65 on 11/18/24 | 163.66 on 11/04/24 | ||
| High | 59.39 on 11/11/24 | 81.73 on 10/28/24 | 207.84 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -12.71% since 08/22/24 | -18.28% since 08/22/24 | -3.60% since 08/22/24 | ||
| Low | 47.41 on 11/22/24 | 47.65 on 11/18/24 | 163.66 on 11/04/24 | ||
| High | 59.39 on 11/11/24 | 81.73 on 10/28/24 | 207.84 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | -17.10% since 05/22/24 | -16.54% since 05/22/24 | +12.50% since 05/22/24 | ||
| Low | 46.25 on 05/28/24 | 46.11 on 06/26/24 | 154.50 on 05/29/24 | ||
| High | 61.38 on 07/26/24 | 81.73 on 10/28/24 | 219.34 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,794,487 | 5,860,419 | 5,476,093 | ||
| Shares Outstanding, K | 118,014 | 111,436 | 28,761 | ||
| Annual Sales | 7,530,000 | 0 | 50,700,000 | ||
| Annual Net Income | -526,240,000 | -85,900,000 | 10,930,000 | ||
| Last Quarter Sales | 460,000 | 0 | 83,840,000 | ||
| Last Quarter Net Income | -160,550,000 | -24,940,000 | 27,180,000 | ||
| 60-Month Beta | 0.78 | 1.00 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.36 on 11/06/24 | -0.22 on 10/23/24 | 0.91 on 11/04/24 | ||
| Latest Earnings Date | 11/06/24 | 10/23/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 86.80 | ||